<DOC>
	<DOCNO>NCT02047838</DOCNO>
	<brief_summary>This retrospective case-control study perform Academic centre diagnosis treatment endometriosis . It include patient recurrent unilateral endometriomas previously operate condition ( case ) patient without recurrency previously underwent surgery unilateral endometrioma ( control ) . The primary outcome study assess impact ovarian reserve second surgery recurrent unilateral endometriomas . The evaluation ovarian reserve perform assess serum anti-mullerian hormone ( AMH ) level , serum follicle-stimulating hormone ( FSH ) level , 17-beta estradiol level antral follicle count ( AFC ) .</brief_summary>
	<brief_title>Second Laparoscopic Surgery Recurrent Unilateral Endometriomas .</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>reproductive age ( time surgical procedure ) ; two surgical procedure ovary ( strip endometrioma large diameter ≥ 4 cm ; case ) perform Institution ; one surgical procedure ( strip endometrioma large diameter ≥ 4 cm ; control ) perform Institution ; histological diagnosis ovarian endometriomas ; complete assessment ovarian reserve routinary followup institution . patient age ≥ 40 year time primary surgery ; surgical procedure contralateral ovary ( primary secondline surgery ) ; previous salpingectomy hysterectomy ; unilateral ovariectomy time first second surgery ; ultrasonographic diagnosis persistent endometrioma first surgery ; additional surgical procedure endometriomas ovarian disease first surgery first second surgery ; hormonal treatment within 3 month ovarian reserve assessment ; patient followedup &lt; 3 month secondline surgery ( case ) . pregnancy and/or breastfeed study period .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>